JULIO
CORTIJO GIMENO
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Miguel Servet
Zaragoza, EspañaPublicacións en colaboración con investigadores/as de Hospital Miguel Servet (4)
2022
-
Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 4, pp. 637-646
2021
-
Dacomitinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: A cost-effectiveness analysis
Journal of Comparative Effectiveness Research, Vol. 10, Núm. 4, pp. 325-335
2019
-
Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: A cost-effectiveness analysis
Journal of Comparative Effectiveness Research, Vol. 8, Núm. 11, pp. 853-863
2016
-
Expression of aquaporins 1 and 5 in a model of ventilator-induced lung injury and its relation to tidal volume
Experimental Physiology, Vol. 101, Núm. 11, pp. 1418-1431